Literature DB >> 9602768

Modified Chiari osteotomy for arthrosis after Perthes' disease. 14 hips followed for 2-12 years.

K Koyama1, F Higuchi, A Inoue.   

Abstract

Between 1983 and 1995, a modified Chiari pelvic osteotomy was performed for coxarthrosis after Perthes' disease in 13 patients (14 hips). The median age at operation was 33 (16-56) years. The median duration of follow-up was 6 (2-12) years. The center-edge angle, Sharp's angle, acetabulum head index and acetabular edge angle improved substantially. The median hip score substantially improved from 76 (46-90) points to 91 (71-100) points at the most recent follow-up examination. We recommend this procedure for patients who have early arthrosis, acetabular dysplasia, pain and good range of motion.

Entities:  

Mesh:

Year:  1998        PMID: 9602768     DOI: 10.3109/17453679809117612

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  4 in total

1.  Intertrochanteric osteotomy in young adults for sequelae of Legg-Calvé-Perthes' disease--a long term follow-up.

Authors:  G A B M Pécasse; H Eijer; D Haverkamp; R K Marti
Journal:  Int Orthop       Date:  2003-10-07       Impact factor: 3.075

2.  Treatment of severe late-onset Perthes' disease with soft tissue release and articulated hip distraction: revisited at skeletal maturity.

Authors:  Eitan Segev; Eli Ezra; Shlomo Wientroub; Moshe Yaniv; Shlomo Hayek; Yoram Hemo
Journal:  J Child Orthop       Date:  2007-09-27       Impact factor: 1.548

3.  Clinical Outcomes Evaluation of Combined Valgus and Chiari Osteotomy Inconsistent with Patient Satisfaction.

Authors:  Akira Hozumi; Kennichi Kidera; Ko Chiba; Takayuki Shida; Makoto Osaki
Journal:  Biomed Res Int       Date:  2018-04-18       Impact factor: 3.411

4.  Treatment outcome of dome osteotomy of the pelvis combined with trochanteric advancement for sequelae of Perthes' disease.

Authors:  Asep Santoso; Pramod Shaligram Ingale; Ik-Sun Choi; Young-Rok Shin; Kyung-Soon Park; Taek-Rim Yoon
Journal:  Acta Orthop Traumatol Turc       Date:  2018-03-26       Impact factor: 1.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.